rdf:type |
|
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0018270,
umls-concept:C0018283,
umls-concept:C0021665,
umls-concept:C0037083,
umls-concept:C0040132,
umls-concept:C0105770,
umls-concept:C0225369,
umls-concept:C1314939,
umls-concept:C1511938,
umls-concept:C1709059,
umls-concept:C1710082
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-5-24
|
pubmed:abstractText |
Thyroid hormone regulates terminal differentiation of growth plate chondrocytes in part through modulation of the Wnt/beta-catenin signaling pathway. Insulin-like growth factor 1 (IGF-1) has been described as a stabilizer of beta-catenin, and thyroid hormone is a known stimulator of IGF-1 receptor expression. The purpose of this study was to test the hypothesis that IGF-1 signaling is involved in the interaction between the thyroid hormone and the Wnt/beta-catenin signaling pathways in regulating growth plate chondrocyte proliferation and differentiation. The results show that IGF-1 and the IGF- receptor (IGF1R) stimulate Wnt-4 expression and beta-catenin activation in growth plate chondrocytes. The positive effects of IGF-1/IGF1R on chondrocyte proliferation and terminal differentiation are partially inhibited by the Wnt antagonists sFRP3 and Dkk1. T(3) activates IGF-1/IGF1R signaling and IGF-1-dependent PI3K/Akt/GSK-3beta signaling in growth plate chondrocytes undergoing proliferation and differentiation to prehypertrophy. T(3)-mediated Wnt-4 expression, beta-catenin activation, cell proliferation, and terminal differentiation of growth plate chondrocytes are partially prevented by the IGF1R inhibitor picropodophyllin as well as by the PI3K/Akt signaling inhibitors LY294002 and Akti1/2. These data indicate that the interactions between thyroid hormone and beta-catenin signaling in regulating growth plate chondrocyte proliferation and terminal differentiation are modulated by IGF-1/IGF1R signaling through both the Wnt and PI3K/Akt signaling pathways. While chondrocyte proliferation may be triggered by the IGF-1/IGF1R-mediated PI3K/Akt/GSK3beta pathway, cell hypertrophy is likely due to activation of Wnt/beta-catenin signaling, which is at least in part initiated by IGF-1 signaling or the IGF-1-activated PI3K/Akt signaling pathway.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-10544181,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-10862751,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-11014246,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-11035789,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-12432069,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-12466191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-12748651,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-12782654,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-14749359,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-15130559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-15334055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-15590974,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-15845624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-16051666,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-16793760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-16857753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17337262,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17431620,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17446238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17592018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17708712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-17960591,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-18397998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-18405384,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-8063865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-8132746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-8402901,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20200966-8402902
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Podophyllotoxin,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine,
http://linkedlifedata.com/resource/pubmed/chemical/Wnt Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Wnt4 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin,
http://linkedlifedata.com/resource/pubmed/chemical/picropodophyllin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1523-4681
|
pubmed:author |
|
pubmed:copyrightInfo |
(c) 2010 American Society for Bone and Mineral Research.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1138-46
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20200966-Animals,
pubmed-meshheading:20200966-Cell Differentiation,
pubmed-meshheading:20200966-Cell Proliferation,
pubmed-meshheading:20200966-Cells, Cultured,
pubmed-meshheading:20200966-Chondrocytes,
pubmed-meshheading:20200966-Growth Plate,
pubmed-meshheading:20200966-Insulin-Like Growth Factor I,
pubmed-meshheading:20200966-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:20200966-Podophyllotoxin,
pubmed-meshheading:20200966-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:20200966-Rats,
pubmed-meshheading:20200966-Rats, Sprague-Dawley,
pubmed-meshheading:20200966-Receptor, IGF Type 1,
pubmed-meshheading:20200966-Signal Transduction,
pubmed-meshheading:20200966-Triiodothyronine,
pubmed-meshheading:20200966-Wnt Proteins,
pubmed-meshheading:20200966-Wnt4 Protein,
pubmed-meshheading:20200966-beta Catenin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
|
pubmed:affiliation |
Orthopaedic Research Center, Department of Orthopaedic Surgery, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|